z-logo
open-access-imgOpen Access
2SPD-013 Economic impact of biosimilar infliximab use
Author(s) -
Carlos Iglesias Fernández,
S Ruiz-Fuentes,
S Belda-Rustarazo,
Celia Gómez-Peña,
R Morón-Romero,
P Gómez-Nieto
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.34
Subject(s) - biosimilar , infliximab , medicine , medical prescription , pharmacy , observational study , drug , intensive care medicine , pharmacology , family medicine , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom